CARsgen® U.S. Clinical Holds Lifted by FDA

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 54 55 56 57 58 59 60 Next Tail

10 Items Per Page (Page 57 / 422) Total 4211 Items

©copyright 2009-2020 Nederlands Dagblad      Contact Us   SiteMap